- February 3, 2016 | BY
The first in vivo genome editing compound is cleared for human trials, a major milestone in the rejuvenated field of gene therapy.
- February 1, 2016 | BY
Outsourced Pharma’s in-depth look at an issue preoccupying the microbial detection field.
- January 29, 2016 | BY
Better tests for Zika, more evidence that AD transmits, and why identical twins diverge on weight.
- January 28, 2016 | BY
An interview with cardiology expert Philip Sager on regulatory changes that are transforming cardiac safety testing.
- January 22, 2016 | BY
Stem cells and multiple sclerosis, an unusual deal to ensure the Ebola vaccine stockpile, a potential new planet on the horizon, and science at Davos.
- January 20, 2016 | BY
How are we faring in the global fight against neglected tropical diseases? A Q&A with Peter Hotez.
- January 19, 2016 | BY
Shedding light on data gaps that have held back the use of this research animal.
- January 15, 2016 | BY
A new global scourge, Obama’s moonshot at cancer and a proposal to use CRISPR in human embryo research.
- January 11, 2016 | BY
Recent FDA guidance on the development and validation of biomarkers was supposed to address questions about the accuracy and reliability of the data. Instead, it triggered debate
- January 8, 2016 | BY
The plight of the missing rodents, the future of optogenetics, the links between insomnia and dementia, and newcomers to the Periodic Table.